When will Novartis release earnings and why does it matter for NOVN.SW stock?

Novartis reports on **04 Feb 2026**. The report matters because sales, margins, and guidance can move NOVN.SW stock quickly and reset near-term targets and sector comparisons.

What are the key valuation metrics to watch for NOVN.SW stock?

Watch **PE 20.54**, EPS **5.58**, price to book **6.52**, and free cash flow per share **9.39**. These metrics show earnings power and capital return capacity ahead of the report.

How does Meyka AI view NOVN.SW short term price prospects?

Meyka AI's model projects monthly **CHF123.14**, implying **+6.25%** upside to current **CHF115.90**. Forecasts are model outputs and not guarantees, used for scenario planning.

Where can I find sector context and recent Novartis news?

Sector data and recent headlines help frame results. See Novartis coverage on Investing.com and Roche sector moves on Investing.com for context [source](https://nl.investing.com/equities/novartis) [source](https://au.investing.com/equities/roche-hldg)

CH Stocks

NOVN.SW Novartis (SIX) CHF115.90 intraday 02 Feb 2026: Earnings 04 Feb could guide next move

ByHuzaifa Zahoor February 2, 2026

The NOVN.SW stock trades at CHF115.90 intraday on 02 Feb 2026 as investors position ahead of Novartis earnings on 04 Feb 2026. The share is up 1.42% today on volume of 577,433 against an average of 2,932,056. Key fundamentals show EPS 5.58 and PE 20.54, with market cap CHF219.93B on the SIX exchange in Switzerland. This earnings spotlight examines drivers, risks, and short-term price signals that could shape the stock after the report.